A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients.

Abstract

This analysis has helped us to secure funding for patients with cystic fibrosis and it facilitates the prediction of future requirements. The study also indicates the limitations of using average patient costs and difficulties as a result of the poorly structured British National Health Service accounting and information systems.